Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 20 entries
Sorted by: Best Match Show Resources per page
Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers.

European journal of radiology

Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C.
PMID: 34902667
Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26.

PURPOSE: Breast cancer gene (BRCA) 1 and 2 mutations are frequently studied gene mutations (GM); the incidence of checkpoint kinase 2 (CHEK2) is increasing. We describe the imaging features of breast cancer (BC) in CHEK2 mutations, compared to BRCA...

Cite
Ghunaim H, Laenen A, De Keyzer F, et al. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021;146:110074doi: 10.1016/j.ejrad.2021.110074.
Ghunaim, H., Laenen, A., De Keyzer, F., Soens, J., Keupers, M., Postema, S., Neven, P., & Van Ongeval, C. (2021). Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. European journal of radiology, 146110074. https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim, Hadeel, et al. "Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers." European journal of radiology vol. 146 (2021): 110074. doi: https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26. PMID: 34902667.
Copy Download .nbib Format: NLM
Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers.

European journal of radiology

Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C.
PMID: 34902667
Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26.

PURPOSE: Breast cancer gene (BRCA) 1 and 2 mutations are frequently studied gene mutations (GM); the incidence of checkpoint kinase 2 (CHEK2) is increasing. We describe the imaging features of breast cancer (BC) in CHEK2 mutations, compared to BRCA...

Cite
Ghunaim H, Laenen A, De Keyzer F, et al. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021;146:110074doi: 10.1016/j.ejrad.2021.110074.
Ghunaim, H., Laenen, A., De Keyzer, F., Soens, J., Keupers, M., Postema, S., Neven, P., & Van Ongeval, C. (2021). Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. European journal of radiology, 146110074. https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim, Hadeel, et al. "Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers." European journal of radiology vol. 146 (2021): 110074. doi: https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26. PMID: 34902667.
Copy Download .nbib Format: NLM
Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2- early breast cancer.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Slembrouck L, Vanden Bempt I, Wildiers H, Smeets A, Van Rompuy AS, Van Ongeval C, Jongen L, Weltens C, Punie K, Hoste G, Van Nieuwenhuysen E, Han S, Nevelsteen I, Neven P, Floris G.
PMID: 33558657
Mod Pathol. 2021 Jul;34(7):1297-1309. doi: 10.1038/s41379-021-00743-8. Epub 2021 Feb 08.

Multigene signatures (MGS) are used to guide adjuvant chemotherapy (aCT) decisions in patients diagnosed with estrogen receptor (ER)-positive HER2-negative early breast cancer. We used results from three MGS (Oncotype DX® (ODX), MammaPrint® (MP) or Prosigna®) and assessed the concordance...

Cite
Slembrouck L, Vanden Bempt I, Wildiers H, et al. Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2- early breast cancer. Mod Pathol. 2021;34(7):1297-1309doi: 10.1038/s41379-021-00743-8.
Slembrouck, L., Vanden Bempt, I., Wildiers, H., Smeets, A., Van Rompuy, A. S., Van Ongeval, C., Jongen, L., Weltens, C., Punie, K., Hoste, G., Van Nieuwenhuysen, E., Han, S., Nevelsteen, I., Neven, P., & Floris, G. (2021). Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2- early breast cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 34(7), 1297-1309. https://doi.org/10.1038/s41379-021-00743-8
Slembrouck, Laurence, et al. "Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2- early breast cancer." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 34,7 (2021): 1297-1309. doi: https://doi.org/10.1038/s41379-021-00743-8
Slembrouck L, Vanden Bempt I, Wildiers H, Smeets A, Van Rompuy AS, Van Ongeval C, Jongen L, Weltens C, Punie K, Hoste G, Van Nieuwenhuysen E, Han S, Nevelsteen I, Neven P, Floris G. Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2- early breast cancer. Mod Pathol. 2021 Jul;34(7):1297-1309. doi: 10.1038/s41379-021-00743-8. Epub 2021 Feb 08. PMID: 33558657.
Copy Download .nbib Format: NLM
Lactating Adenoma in the Presence of Galactoceles.

JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)

Lefere I, Van Ongeval C, Van Steen A, Oyen R.
PMID: 30394444
JBR-BTR. 2015 Jun 01;98(3):131-132. doi: 10.5334/jbr-btr.799.

BACKGROUND: A 22-year-old woman was referred to our department with a painless, fast growing breast mass. She noticed this mass during lactation, after giving birth to her first child. Her gynecologist palpated a large mass in the left breast,...

Cite
Lefere I, Van Ongeval C, Van Steen A, et al. Lactating Adenoma in the Presence of Galactoceles. JBR-BTR. 2015;98(3):131-132doi: 10.5334/jbr-btr.799.
Lefere, I., Van Ongeval, C., Van Steen, A., & Oyen, R. (2015). Lactating Adenoma in the Presence of Galactoceles. JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR), 98(3), 131-132. https://doi.org/10.5334/jbr-btr.799
Lefere, I, et al. "Lactating Adenoma in the Presence of Galactoceles." JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR) vol. 98,3 (2015): 131-132. doi: https://doi.org/10.5334/jbr-btr.799
Lefere I, Van Ongeval C, Van Steen A, Oyen R. Lactating Adenoma in the Presence of Galactoceles. JBR-BTR. 2015 Jun 01;98(3):131-132. doi: 10.5334/jbr-btr.799. PMID: 30394444.
Copy Download .nbib Format: NLM
Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers.

European journal of radiology

Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C.
PMID: 34902667
Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26.

PURPOSE: Breast cancer gene (BRCA) 1 and 2 mutations are frequently studied gene mutations (GM); the incidence of checkpoint kinase 2 (CHEK2) is increasing. We describe the imaging features of breast cancer (BC) in CHEK2 mutations, compared to BRCA...

Cite
Ghunaim H, Laenen A, De Keyzer F, et al. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021;146:110074doi: 10.1016/j.ejrad.2021.110074.
Ghunaim, H., Laenen, A., De Keyzer, F., Soens, J., Keupers, M., Postema, S., Neven, P., & Van Ongeval, C. (2021). Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. European journal of radiology, 146110074. https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim, Hadeel, et al. "Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers." European journal of radiology vol. 146 (2021): 110074. doi: https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26. PMID: 34902667.
Copy Download .nbib Format: NLM
Getting Rid of Patient's Misconceptions About the Radiology Department Using Animated Video in the Waiting Room.

Journal of the Belgian Society of Radiology

Lavaerts M, Vandenhout H, Oyen R, Van Ongeval C.
PMID: 34396038
J Belg Soc Radiol. 2021 Jul 29;105(1):41. doi: 10.5334/jbsr.2405. eCollection 2021.

OBJECTIVES: Patients often confuse the role of the radiologist with that of the technician. The aim of this study is to explore patients' current perceptions about the radiology department and to evaluate how it's possible to get rid of...

Cite
Lavaerts M, Vandenhout H, Oyen R, et al. Getting Rid of Patient's Misconceptions About the Radiology Department Using Animated Video in the Waiting Room. J Belg Soc Radiol. 2021;105(1):41doi: 10.5334/jbsr.2405.
Lavaerts, M., Vandenhout, H., Oyen, R., & Van Ongeval, C. (2021). Getting Rid of Patient's Misconceptions About the Radiology Department Using Animated Video in the Waiting Room. Journal of the Belgian Society of Radiology, 105(1), 41. https://doi.org/10.5334/jbsr.2405
Lavaerts, Michel, et al. "Getting Rid of Patient's Misconceptions About the Radiology Department Using Animated Video in the Waiting Room." Journal of the Belgian Society of Radiology vol. 105,1 (2021): 41. doi: https://doi.org/10.5334/jbsr.2405
Lavaerts M, Vandenhout H, Oyen R, Van Ongeval C. Getting Rid of Patient's Misconceptions About the Radiology Department Using Animated Video in the Waiting Room. J Belg Soc Radiol. 2021 Jul 29;105(1):41. doi: 10.5334/jbsr.2405. eCollection 2021. PMID: 34396038; PMCID: PMC8323534.
Copy Download .nbib Format: NLM
Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers.

European journal of radiology

Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C.
PMID: 34902667
Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26.

PURPOSE: Breast cancer gene (BRCA) 1 and 2 mutations are frequently studied gene mutations (GM); the incidence of checkpoint kinase 2 (CHEK2) is increasing. We describe the imaging features of breast cancer (BC) in CHEK2 mutations, compared to BRCA...

Cite
Ghunaim H, Laenen A, De Keyzer F, et al. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021;146:110074doi: 10.1016/j.ejrad.2021.110074.
Ghunaim, H., Laenen, A., De Keyzer, F., Soens, J., Keupers, M., Postema, S., Neven, P., & Van Ongeval, C. (2021). Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. European journal of radiology, 146110074. https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim, Hadeel, et al. "Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers." European journal of radiology vol. 146 (2021): 110074. doi: https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26. PMID: 34902667.
Copy Download .nbib Format: NLM
Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers.

European journal of radiology

Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C.
PMID: 34902667
Eur J Radiol. 2022 Jan;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26.

PURPOSE: Breast cancer gene (BRCA) 1 and 2 mutations are frequently studied gene mutations (GM); the incidence of checkpoint kinase 2 (CHEK2) is increasing. We describe the imaging features of breast cancer (BC) in CHEK2 mutations, compared to BRCA...

Cite
Ghunaim H, Laenen A, De Keyzer F, et al. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021;146:110074doi: 10.1016/j.ejrad.2021.110074.
Ghunaim, H., Laenen, A., De Keyzer, F., Soens, J., Keupers, M., Postema, S., Neven, P., & Van Ongeval, C. (2022). Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. European journal of radiology, 146110074. https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim, Hadeel, et al. "Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers." European journal of radiology vol. 146 (2022): 110074. doi: https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2022 Jan;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26. PMID: 34902667.
Copy Download .nbib Format: NLM
Virtual clinical trial to compare cancer detection using combinations of 2D mammography, digital breast tomosynthesis and synthetic 2D imaging.

European radiology

Mackenzie A, Thomson EL, Mitchell M, Elangovan P, van Ongeval C, Cockmartin L, Warren LM, Wilkinson LS, Wallis MG, Given-Wilson RM, Dance DR, Young KC.
PMID: 34331118
Eur Radiol. 2021 Jul 30; doi: 10.1007/s00330-021-08197-x. Epub 2021 Jul 30.

OBJECTIVES: This study was designed to compare the detection of subtle lesions (calcification clusters or masses) when using the combination of digital breast tomosynthesis (DBT) and synthetic mammography (SM) with digital mammography (DM) alone or combined with DBT.METHODS: A...

Cite
Mackenzie A, Thomson EL, Mitchell M, et al. Virtual clinical trial to compare cancer detection using combinations of 2D mammography, digital breast tomosynthesis and synthetic 2D imaging. Eur Radiol. 2021;doi: 10.1007/s00330-021-08197-x.
Mackenzie, A., Thomson, E. L., Mitchell, M., Elangovan, P., van Ongeval, C., Cockmartin, L., Warren, L. M., Wilkinson, L. S., Wallis, M. G., Given-Wilson, R. M., Dance, D. R., & Young, K. C. (2021). Virtual clinical trial to compare cancer detection using combinations of 2D mammography, digital breast tomosynthesis and synthetic 2D imaging. European radiology, . https://doi.org/10.1007/s00330-021-08197-x
Mackenzie, Alistair, et al. "Virtual clinical trial to compare cancer detection using combinations of 2D mammography, digital breast tomosynthesis and synthetic 2D imaging." European radiology vol. (2021). doi: https://doi.org/10.1007/s00330-021-08197-x
Mackenzie A, Thomson EL, Mitchell M, Elangovan P, van Ongeval C, Cockmartin L, Warren LM, Wilkinson LS, Wallis MG, Given-Wilson RM, Dance DR, Young KC. Virtual clinical trial to compare cancer detection using combinations of 2D mammography, digital breast tomosynthesis and synthetic 2D imaging. Eur Radiol. 2021 Jul 30; doi: 10.1007/s00330-021-08197-x. Epub 2021 Jul 30. PMID: 34331118.
Copy Download .nbib Format: NLM
Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers.

European journal of radiology

Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C.
PMID: 34902667
Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26.

PURPOSE: Breast cancer gene (BRCA) 1 and 2 mutations are frequently studied gene mutations (GM); the incidence of checkpoint kinase 2 (CHEK2) is increasing. We describe the imaging features of breast cancer (BC) in CHEK2 mutations, compared to BRCA...

Cite
Ghunaim H, Laenen A, De Keyzer F, et al. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021;146:110074doi: 10.1016/j.ejrad.2021.110074.
Ghunaim, H., Laenen, A., De Keyzer, F., Soens, J., Keupers, M., Postema, S., Neven, P., & Van Ongeval, C. (2021). Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. European journal of radiology, 146110074. https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim, Hadeel, et al. "Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers." European journal of radiology vol. 146 (2021): 110074. doi: https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26. PMID: 34902667.
Copy Download .nbib Format: NLM
Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers.

European journal of radiology

Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C.
PMID: 34902667
Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26.

PURPOSE: Breast cancer gene (BRCA) 1 and 2 mutations are frequently studied gene mutations (GM); the incidence of checkpoint kinase 2 (CHEK2) is increasing. We describe the imaging features of breast cancer (BC) in CHEK2 mutations, compared to BRCA...

Cite
Ghunaim H, Laenen A, De Keyzer F, et al. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021;146:110074doi: 10.1016/j.ejrad.2021.110074.
Ghunaim, H., Laenen, A., De Keyzer, F., Soens, J., Keupers, M., Postema, S., Neven, P., & Van Ongeval, C. (2021). Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. European journal of radiology, 146110074. https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim, Hadeel, et al. "Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers." European journal of radiology vol. 146 (2021): 110074. doi: https://doi.org/10.1016/j.ejrad.2021.110074
Ghunaim H, Laenen A, De Keyzer F, Soens J, Keupers M, Postema S, Neven P, Van Ongeval C. Comparing breast cancer imaging characteristics of CHEK2 with BRCA1 and BRCA2 gene mutation carriers. Eur J Radiol. 2021 Nov 26;146:110074. doi: 10.1016/j.ejrad.2021.110074. Epub 2021 Nov 26. PMID: 34902667.
Copy Download .nbib Format: NLM
International Day of Radiology: Breast Imaging.

Journal of the Belgian Society of Radiology

Van Ongeval C, Soens J, Van Goethem M.
PMID: 30038990
J Belg Soc Radiol. 2016 Nov 19;100(1):107. doi: 10.5334/jbr-btr.1232.

November 8, 2016, is the International Day of Radiology (IDoR), which is dedicated to breast imaging and the essential role that radiology plays in the detection, diagnosis, and management of diseases of the breast (http://www.internationaldayofradiology.com). On the website, you...

Cite
Van Ongeval C, Soens J, Van Goethem M. International Day of Radiology: Breast Imaging. J Belg Soc Radiol. 2016;100(1):107doi: 10.5334/jbr-btr.1232.
Van Ongeval, C., Soens, J., & Van Goethem, M. (2016). International Day of Radiology: Breast Imaging. Journal of the Belgian Society of Radiology, 100(1), 107. https://doi.org/10.5334/jbr-btr.1232
Van Ongeval, Chantal, et al. "International Day of Radiology: Breast Imaging." Journal of the Belgian Society of Radiology vol. 100,1 (2016): 107. doi: https://doi.org/10.5334/jbr-btr.1232
Van Ongeval C, Soens J, Van Goethem M. International Day of Radiology: Breast Imaging. J Belg Soc Radiol. 2016 Nov 19;100(1):107. doi: 10.5334/jbr-btr.1232. PMID: 30038990; PMCID: PMC5854275.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 20 entries